ORGANON & CO. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.55 USD | +0.71% |
|
+4.10% | +28.64% |
| 04-09 | Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating | MT |
| 04-08 | Shanghai Henlius Biotech Denosumab Biosimilar HLX14 Meets Endpoint | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 18.80 | 18.80 | 23.15 |
| Spread/Res. | -1.33% | -1.33% | -19.87% |
| Spread/Supp. | +6.30% | +28.64% | +68.33% |
| Support | 17.45 | 14.42 | 11.02 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- OGN Stock
- Charts Organon & Co.
